CEO, HELIO GENOMICS
WHY: Leads cancer diagnostics firm that’s one of the better-funded MedTech companies in OC. Raised $165M as of July.
IN THE NEWS: China’s equivalent of the FDA in July approved a liver cancer detection test from Helio’s sister company, Laboratory for Advanced Medicine & Health Group. Helio expects to get FDA’s greenlight for its liver cancer test next year.
NOTABLE: Won the Business Journal’s Innovator of the Year Award in 2022 for launching a liver cancer test in partnership with Fulgent Genetics (Nasdaq: FLGT). Motivated to develop early-stage cancer tests due to grandfather dying from lung cancer.
